Persistence Pays Off for Praxis as Essential Tremor Drug Succeeds in Two Pivotal Studies
Seven months ago, independent clinical trial observers peeked at interim data for Praxis Precision Medicines’ essential tremor drug and recommended ...
Sunday, December 14, 2025
Tag: drug
Boehringer Ingelheim Drug Wins FDA Approval for Treating Fatal Lung Disorder IPF
Boehringer Ingelheim established a presence in idiopathic pulmonary fibrosis years ago with a drug that has become a standard treatment ...
Pfizer Reaches Deal on Most-Favored Nation Drug Pricing; Other Pharmas Expected to Follow
Pfizer is the first big pharmaceutical company to reach an agreement with the Trump administration over most-favored nation drug pricing, ...
Genmab to Pay $8B to Get Its Hands on Merus Head & Neck Cancer Drug With Blockbuster Potential
Genmab’s growth and pipeline diversification strategy is picking up another piece through the acquisition of Merus in an $8 billion ...
Ionis Pharma’s Drug for Rare Disease With No Approved Therapies Meets Goals of Pivotal Study
Patients who have a particular genetic disease whose symptoms include progressively worsening muscle control were able to walk faster following ...
Roche’s Metabolic Drug Strategy Extends to the Liver Disease MASH With $2.4B 89bio Acquisition
There are two FDA-approved medications for the metabolic disorder known as MASH. Roche is paying $2.4 billion to acquire 89bio ...
Cocaine is more popular than ever in the US and the Mexican drug lord Trump has declared war on is cashing in
The latest headlines from our reporters across the US sent straight to your inbox each weekdayYour briefing on the latest ...
With Drug Picked Up From Sanofi, Startup AllRock Takes Aim at Two Severe Lung Diseases
The target of AllRock Bio’s research is already validated by FDA-approved medicines — for the eyes. The biotech startup is ...
Maze Therapeutics Drug Shows Potential to Top Asset Acquired by Otsuka for $800M
An experimental Maze Therapeutics drug increased urinary excretion of compounds that are biological indicators of metabolic disease, early clinical trial ...
Long Regulatory Saga for Intercept Pharma Liver Drug Ends a Decade After Speedy FDA Approval
While the path for any drug to go from lab research to commercialization takes years, Intercept Pharmaceuticals now stands as ...